The present invention refers to pharmaceutical beclomethasone dipropionate compositions in modified-release gastro-resistant microspheres and to their oral use in the treatment of inflammatory pathologies of the intestinal tract. Said compositions in microspheres consist of: a) a core consisting of a microsphere of inert material； b) a first intermediate coating comprising beclomethasone dipropionate and at least one physiologically acceptable excipient； c) a second modified-release gastro-resistant coating. The present disclosure also refers to a process for obtaining said compositions.
